Is Acura Pharmaceuticals, Inc. (ACUR) a Buy, Sell, or Hold?
OTC : ACUR
Acura Pharmaceuticals, Inc. — Insider Trades
$0.0003 USD
$0.0 (200.0%)
- Volume
- 400
- Average Volume
- 327
- Market Capitalization
- $19.8K
- P/E Ratio
- -0.02
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.01
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.72
Insider Activity Summary (Last 12 Months)
Insiders Buying
26
Insiders Selling
18
Amount of Insider Selling
$896.66K
ACUR Insider Buying/Selling by Quarter
ACUR Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| THANGARAJ IMMANUEL | director | 2026-01-02 | M-Exempt | 0.01 | 2026-01-15 |
| THANGARAJ IMMANUEL | director | 2026-01-02 | A-Award | 0 | 2026-01-15 |
| THANGARAJ IMMANUEL | director | 2026-01-02 | M-Exempt | 0 | 2026-01-15 |
| SKELLY WILLIAM G | director | 2026-01-02 | M-Exempt | 0.01 | 2026-01-15 |
| SKELLY WILLIAM G | director | 2026-01-02 | A-Award | 0 | 2026-01-15 |
| SKELLY WILLIAM G | director | 2026-01-02 | M-Exempt | 0 | 2026-01-15 |
| ROSS GEORGE K | director | 2026-01-02 | M-Exempt | 0.01 | 2026-01-15 |
| ROSS GEORGE K | director | 2026-01-02 | A-Award | 0 | 2026-01-15 |
| ROSS GEORGE K | director | 2026-01-02 | M-Exempt | 0 | 2026-01-15 |
| THANGARAJ IMMANUEL | director | 2025-01-02 | M-Exempt | 0.01 | 2025-02-04 |
| THANGARAJ IMMANUEL | director | 2025-01-02 | A-Award | 0 | 2025-02-04 |
| THANGARAJ IMMANUEL | director | 2025-01-02 | M-Exempt | 0 | 2025-02-04 |
| SKELLY WILLIAM G | director | 2025-01-02 | M-Exempt | 0.01 | 2025-01-24 |
| SKELLY WILLIAM G | director | 2025-01-02 | A-Award | 0 | 2025-01-24 |
| SKELLY WILLIAM G | director | 2025-01-02 | M-Exempt | 0 | 2025-01-24 |
| ROSS GEORGE K | director | 2025-01-02 | M-Exempt | 0.01 | 2025-01-24 |
| ROSS GEORGE K | director | 2025-01-02 | A-Award | 0 | 2025-01-24 |
| ROSS GEORGE K | director | 2025-01-02 | M-Exempt | 0 | 2025-01-24 |
| ROSS GEORGE K | director | 2024-01-02 | M-Exempt | 0.01 | 2024-01-02 |
| ROSS GEORGE K | director | 2024-01-02 | A-Award | 0 | 2024-01-02 |
| ROSS GEORGE K | director | 2024-01-02 | M-Exempt | 0 | 2024-01-02 |
| SKELLY WILLIAM G | director | 2024-01-02 | M-Exempt | 0.01 | 2024-01-02 |
| SKELLY WILLIAM G | director | 2024-01-02 | A-Award | 0 | 2024-01-02 |
| SKELLY WILLIAM G | director | 2024-01-02 | M-Exempt | 0 | 2024-01-02 |
| THANGARAJ IMMANUEL | director | 2024-01-02 | M-Exempt | 0.01 | 2024-01-02 |
| THANGARAJ IMMANUEL | director | 2024-01-02 | A-Award | 0 | 2024-01-02 |
| THANGARAJ IMMANUEL | director | 2024-01-02 | M-Exempt | 0 | 2024-01-02 |
| WESSON BRUCE F | director | 2024-01-02 | M-Exempt | 0.01 | 2024-01-02 |
| WESSON BRUCE F | director | 2024-01-02 | M-Exempt | 0 | 2024-01-02 |
| WESSON BRUCE F | director | 2024-01-02 | D-Return | 0 | 2024-01-02 |
| Seiser Robert A | officer: VP, Treasurer & Controller | 2023-11-20 | M-Exempt | 0.01 | 2023-11-20 |
| Seiser Robert A | officer: VP, Treasurer & Controller | 2023-11-20 | M-Exempt | 0.01 | 2023-11-20 |
| Jones Robert B | officer: President & CEO | 2023-11-20 | M-Exempt | 0.01 | 2023-11-20 |
| Jones Robert B | officer: President & CEO | 2023-11-20 | M-Exempt | 0.01 | 2023-11-20 |
| CLEMENS PETER A | officer: Senior VP & CFO | 2023-11-20 | M-Exempt | 0.01 | 2023-11-20 |
| CLEMENS PETER A | officer: Senior VP & CFO | 2023-11-20 | M-Exempt | 0.01 | 2023-11-20 |
| Brzeczko Albert W | officer: See Remarks | 2023-11-20 | M-Exempt | 0.01 | 2023-11-20 |
| Brzeczko Albert W | officer: See Remarks | 2023-11-20 | M-Exempt | 0.01 | 2023-11-20 |
| Seiser Robert A | officer: VP, Treasurer & Controller | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| Seiser Robert A | officer: VP, Treasurer & Controller | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| Jones Robert B | officer: President & CEO | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| Jones Robert B | officer: President & CEO | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| CLEMENS PETER A | officer: Senior VP & CFO | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| CLEMENS PETER A | officer: Senior VP & CFO | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| Brzeczko Albert W | officer: See Remark | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| Brzeczko Albert W | officer: See Remark | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| ROSS GEORGE K | director | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| ROSS GEORGE K | director | 2023-01-03 | A-Award | 0 | 2023-01-05 |
| ROSS GEORGE K | director | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| WESSON BRUCE F | director | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| WESSON BRUCE F | director | 2023-01-03 | A-Award | 0 | 2023-01-05 |
| WESSON BRUCE F | director | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| THANGARAJ IMMANUEL | director | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| THANGARAJ IMMANUEL | director | 2023-01-03 | A-Award | 0 | 2023-01-05 |
| THANGARAJ IMMANUEL | director | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| SKELLY WILLIAM G | director | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| SKELLY WILLIAM G | director | 2023-01-03 | A-Award | 0 | 2023-01-05 |
| SKELLY WILLIAM G | director | 2023-01-03 | M-Exempt | 0 | 2023-01-05 |
| Brzeczko Albert W | officer: VP, Pharma Sciences - APT | 2022-08-03 | M-Exempt | 0.01 | 2022-08-05 |
| Brzeczko Albert W | officer: VP, Pharma Sciences - APT | 2022-08-03 | M-Exempt | 0 | 2022-08-05 |
| Brzeczko Albert W | officer: VP, Pharma Sciences - APT | 2022-08-03 | M-Exempt | 0.01 | 2022-08-05 |
| Brzeczko Albert W | officer: VP, Pharma Sciences - APT | 2022-08-03 | M-Exempt | 0.01 | 2022-08-05 |
| Jones Robert B | officer: President & CEO | 2022-08-03 | M-Exempt | 0 | 2022-08-05 |
| Jones Robert B | officer: President & CEO | 2022-08-03 | M-Exempt | 0.01 | 2022-08-05 |
| Jones Robert B | officer: President & CEO | 2022-08-03 | M-Exempt | 0.01 | 2022-08-05 |
| Jones Robert B | officer: President & CEO | 2022-08-03 | M-Exempt | 0.01 | 2022-08-05 |
| Seiser Robert A | officer: VP, Controller & Treasurer | 2022-08-03 | M-Exempt | 0 | 2022-08-05 |
| CLEMENS PETER A | officer: Senior VP & CFO | 2022-08-03 | M-Exempt | 0.01 | 2022-08-05 |
| CLEMENS PETER A | officer: Senior VP & CFO | 2022-08-03 | M-Exempt | 0.01 | 2022-08-05 |
| CLEMENS PETER A | officer: Senior VP & CFO | 2022-08-03 | M-Exempt | 0 | 2022-08-05 |
| CLEMENS PETER A | officer: Senior VP & CFO | 2022-08-03 | M-Exempt | 0.01 | 2022-08-05 |
| Seiser Robert A | officer: VP, Controller & Treasurer | 2022-03-16 | A-Award | 0 | 2022-03-18 |
| Jones Robert B | officer: President & CEO | 2022-03-16 | A-Award | 0.01 | 2022-03-18 |
| Jones Robert B | officer: President & CEO | 2022-03-16 | A-Award | 0 | 2022-03-18 |
| CLEMENS PETER A | officer: Senior VP & CFO | 2022-03-16 | A-Award | 0 | 2022-03-18 |
| CLEMENS PETER A | officer: Senior VP & CFO | 2022-03-16 | A-Award | 0.01 | 2022-03-18 |
| Brzeczko Albert W | officer: VP, Pharma Sciences - APT | 2022-03-16 | A-Award | 0.01 | 2022-03-18 |
| Brzeczko Albert W | officer: VP, Pharma Sciences - APT | 2022-03-16 | A-Award | 0 | 2022-03-18 |
| THANGARAJ IMMANUEL | director | 2022-01-03 | M-Exempt | 0.01 | 2022-01-12 |
| THANGARAJ IMMANUEL | director | 2022-01-03 | A-Award | 0 | 2022-01-12 |
| THANGARAJ IMMANUEL | director | 2022-01-03 | M-Exempt | 0 | 2022-01-12 |
| WESSON BRUCE F | director | 2022-01-03 | M-Exempt | 0.01 | 2022-01-11 |
| WESSON BRUCE F | director | 2022-01-03 | A-Award | 0 | 2022-01-11 |
| WESSON BRUCE F | director | 2022-01-03 | M-Exempt | 0 | 2022-01-11 |
| ROSS GEORGE K | director | 2022-01-03 | M-Exempt | 0.01 | 2022-01-10 |
| ROSS GEORGE K | director | 2022-01-03 | A-Award | 0 | 2022-01-10 |
| ROSS GEORGE K | director | 2022-01-03 | M-Exempt | 0 | 2022-01-10 |
| SKELLY WILLIAM G | director | 2022-01-03 | M-Exempt | 0.01 | 2022-01-05 |
| SKELLY WILLIAM G | director | 2022-01-03 | A-Award | 0 | 2022-01-05 |
| SKELLY WILLIAM G | director | 2022-01-03 | M-Exempt | 0 | 2022-01-05 |
| Abuse Deterrent Pharma, LLC | 10 percent owner | 2021-06-09 | C-Conversion | 0.16 | 2021-06-28 |
| Abuse Deterrent Pharma, LLC | 10 percent owner | 2021-06-09 | C-Conversion | 0.16 | 2021-06-28 |
| Schutte John | 10 percent owner | 2021-06-09 | C-Conversion | 0.16 | 2021-06-28 |
| Schutte John | 10 percent owner | 2021-06-09 | C-Conversion | 0.16 | 2021-06-28 |
| WESSON BRUCE F | director | 2021-05-25 | A-Award | 0 | 2021-05-28 |
| ROSS GEORGE K | director | 2021-05-25 | A-Award | 0 | 2021-05-28 |
| SKELLY WILLIAM G | director | 2021-05-25 | A-Award | 0 | 2021-05-28 |
| THANGARAJ IMMANUEL | director | 2021-05-25 | A-Award | 0 | 2021-05-28 |
| Seiser Robert A | officer: VP, Treasurer & Controller | 2021-02-24 | M-Exempt | 0.151 | 2021-02-26 |
| Seiser Robert A | officer: VP, Treasurer & Controller | 2021-02-24 | F-InKind | 0.4 | 2021-02-26 |